Press release
Netherton Syndrome Clinical Trials, Pipeline Insights, Treatment Drugs, and Companies 2024
Netherton Syndrome Pipeline
Explore our latest breakthroughs in Netherton Syndrome Research. Learn more about our innovative pipeline today! @ Netherton Syndrome Pipeline Outlook- https://www.delveinsight.com/sample-request/netherton-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Netherton Syndrome Pipeline Report
• In August 2024:- Daiichi Sankyo- A Phase 1b/2, Double-Blind, Placebo-Controlled, Randomized, Parallel-Arm Study to Explore Safety, Pharmacokinetics, and Early Clinical Signal of Efficacy of DS-2325a in Patients With Netherton Syndrome. Netherton Syndrome (NS) is a severe rare disease characterized by generalized scaling, erythema, and epidermal barrier defects. This study assessed the safety, pharmacokinetics (PK), and efficacy of DS-2325a in patients with NS.
• June 2024:- Daiichi Sankyo- A Phase 1b/2, Double-Blind, Placebo-Controlled, Randomized, Parallel-Arm Study to Explore Safety, Pharmacokinetics, and Early Clinical Signal of Efficacy of DS-2325a in Patients With Netherton Syndrome. This study will explore the safety, pharmacokinetics (PK), and early clinical signal efficacy of DS-2325a in adult patients with NS.
• June 2024:- Boehringer Ingelheim- This study is open to people with a skin disease called Netherton syndrome (NS). People can join the study if they are 12 years and older. The purpose of this study is to find out whether a medicine called spesolimab helps people with NS.
• DelveInsight's Netherton Syndrome pipeline report depicts a robust space with 5+ active players working to develop 5+ pipeline therapies for Netherton Syndrome treatment.
• The leading Netherton Syndrome Companies such as TenNor Therapeutics, KBP Biosciences, Debiopharm, Destiny Pharmaa, and others.
• Promising Netherton Syndrome Therapies such as DS-2325a, QRX003, Spesolimab, and others.
Stay informed about the cutting-edge advancements in Netherton Syndrome Treatments. Download for updates and be a part of the revolution in genetic disorder care @ Netherton Syndrome Clinical Trials Assessment- https://www.delveinsight.com/sample-request/netherton-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Netherton Syndrome Emerging Drugs Profile
• QRX003: Quoin Pharmaceuticals
QRX003 is a topical lotion, formulated with a proprietary Invisicare® delivery technology, and contains a broad- spectrum serine protease inhibitor, whose mechanism of action is intended to perform the function of a specific protein, called LEKTI. The absence of LEKTI in Netherton patients leads to excessive skin shedding resulting in a highly porous and compromised skin barrier. QRX003 is designed to lead to a more normalized skin shedding process and the formation of a stronger and more effective skin barrier.
• SXR-1096: Sixera Pharma
SXR1096 is a first-in-class, potent and selective small molecule inhibitor of kallikreins 5, 7 and 14 (KLK5, 7 and 14). The compound is formulated in a proprietary skin cream formulation designed for daily use in patients with rare skin conditions. Due to the inborn lack of the protease inhibitor LEKTI, KLK 5, 7 and 14 are overactive in the outermost layer of the skin in patients with Netherton syndrome. These drug targets can best be reached by applying the pharmaceutical directly on the skin. The disease is manifest from birth and can be life threatening in newborns.
Learn more about Netherton Syndrome Drugs opportunities in our groundbreaking Netherton Syndrome Research and development projects @ Netherton Syndrome Unmet Needs- https://www.delveinsight.com/sample-request/netherton-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Netherton Syndrome pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration
• Oral
• Intravenous
• Subcutaneous
• Parenteral
• Topical
Netherton Syndrome Products have been categorized under various Molecule types such as
• Recombinant fusion proteins
• Small molecule
• Monoclonal antibody
• Peptide
• Polymer
• Gene therapy
Discover the latest advancements in Netherton Syndrome Treatment by visiting our website. Stay informed about how we're transforming the future of genetic disorder @ Netherton Syndrome Market Drivers and Barriers, and Future Perspectives- https://www.delveinsight.com/sample-request/netherton-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Netherton Syndrome Pipeline Report
• Coverage- Global
• Netherton Syndrome Companies- TenNor Therapeutics, KBP Biosciences, Debiopharm, Destiny Pharmaa, and others.
• Netherton Syndrome Therapies- DS-2325a, QRX003, Spesolimab, and others.
• Netherton Syndrome Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Netherton Syndrome Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
For a detailed overview of our latest research findings and future plans, read the full details of Netherton Syndrome Pipeline on our website @ Netherton Syndrome Drugs and Companies- https://www.delveinsight.com/sample-request/netherton-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. Netherton Syndrome: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Netherton Syndrome - DelveInsight's Analytical Perspective
7. Late Stage Products (Phase III)
8. Drug Name: Company Name
9. Drug profiles in the detailed report…..
10. Mid Stage Products (Phase II/III)
11. QRX003: Quoin Pharmaceuticals
12. Drug profiles in the detailed report…..
13. Early Stage Products (Phase I/II)
14. SXR-1096: Sixera Pharma
15. Drug profiles in the detailed report…..
16. Preclinical and Discovery Stage Products
17. Drug Name: Company Name
18. Drug profiles in the detailed report…..
19. Inactive Products
20. Netherton Syndrome Key Companies
21. Netherton Syndrome Key Products
22. Netherton Syndrome- Unmet Needs
23. Netherton Syndrome- Market Drivers and Barriers
24. Netherton Syndrome- Future Perspectives and Conclusion
25. Netherton Syndrome Analyst Views
26. Netherton Syndrome Key Companies
27. Appendix
List of Top Selling Market Research Report in 2024
Brucellosis Market- https://www.delveinsight.com/report-store/brucellosis-market
Pacemakers Market- https://www.delveinsight.com/report-store/pacemakers-market
Surgical Energy Instruments Market- https://www.delveinsight.com/report-store/surgical-energy-generators-market
Intraocular Lymphoma Market- https://www.delveinsight.com/report-store/intraocular-lymphoma-market
Thrombectomy Devices Market- https://www.delveinsight.com/report-store/thrombectomy-devices-market
Ventral Hernia Market- https://www.delveinsight.com/report-store/ventral-hernia-market
Novel Drug Delivery Devices Market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
Skin Neoplasms Market- https://www.delveinsight.com/report-store/skin-neoplasms-market
Hip Replacement Devices Market- https://www.delveinsight.com/report-store/hip-reconstruction-devices-market
Varicose Vein Treatment Devices Market- https://www.delveinsight.com/report-store/varicose-vein-treatment-devices-market
Bone Growth Stimulators Market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Sepsis Market- https://www.delveinsight.com/report-store/sepsis-market
Transcatheter Heart Valve Replacement Devices Market- https://www.delveinsight.com/report-store/transcatheter-heart-valve-replacement-devices-market
Endoscopic Ultrasound Market- https://www.delveinsight.com/report-store/endoscopic-ultrasound-market
Cardiac Monitoring Devices Market- https://www.delveinsight.com/report-store/cardiac-monitoring-devices-market
Trichomoniasis Market- https://www.delveinsight.com/report-store/trichomoniasis-market-insights
Radiodermatitis Market- https://www.delveinsight.com/report-store/radiodermatitis-market
HDAC Inhibitors Market- https://www.delveinsight.com/report-store/hdac-inhibitors-market
CXCR Inhibitors Market- https://www.delveinsight.com/report-store/c-x-c-chemokine-receptor-inhibitors-competitive-landscape-market-and-pipeline-analysis
Lactose Intolerance Market- https://www.delveinsight.com/report-store/lactose-intolerance-market
Total Knee Arthroplasty Market- https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
Microscopy Device Market- https://www.delveinsight.com/report-store/microscopy-device-market
Medical Marijuana Market- https://www.delveinsight.com/report-store/medical-marijuana-market-insight
Pigment Epithelial Detachment Market- https://www.delveinsight.com/report-store/pigment-epithelial-detachment-market
Stem Cell Market- https://www.delveinsight.com/report-store/stem-cell-market
UK Healthcare Report- https://www.delveinsight.com/report-store/uk-healthcare-outlook-report
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Contact No.: +91-9650213330
City: 304 S. Jones Blvd #2432, Las Vegas
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Netherton Syndrome Clinical Trials, Pipeline Insights, Treatment Drugs, and Companies 2024 here
News-ID: 3664975 • Views: …
More Releases from DelveInsight Business Research LLP
ANCA Vasculitis Clinical Trials, Pipeline Insights, Treatment Drugs, and Compani …
DelveInsight's, "ANCA Vasculitis Pipeline Insight 2024" report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in ANCA Vasculitis pipeline landscape. It covers the ANCA Vasculitis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the ANCA Vasculitis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in ANCA Vasculitis…
Dengue Pipeline Insights, Clinical Trials, Treatment Drugs, and Companies 2024
DelveInsight's, "Dengue- Pipeline Insight 2024" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Dengue pipeline landscape. It covers the Dengue pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Dengue Research. Learn more about our innovative…
Behcet's syndrome Market Size is Set for Rapid Growth as Innovative Treatments a …
The Behcet's syndrome market size is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging treatment options by leading companies such as AbbVie, Eisai Co. Ltd, Nobel Pharmaceuticals, Ainos Inc., Amgen, Ganzhou Hemay Pharmaceutical Co. Ltd, Janssen Korea Ltd, Mitsubishi Tanabe Pharma Corporation, Bristol-Myers Squibb, Hoffmann- La Roche, Novartis Pharmaceuticals, Abbott, Sanguine Biosciences, GlaxoSmithKline, IItoo Pharma
[Nevada, United States] - DelveInsight's "Behcet's syndrome Market…
Tendinopathy Market Size is Set for Rapid Growth as Innovative Treatments and Ri …
The Tendinopathy market size is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging treatment options by leading companies such as MiMedx Group, Novartis Pharmaceuticals, Ipsen, Orthocell Limited, ZARS Pharma Inc., Zimmer Biomet, Causeway Therapeutics, Travanti Pharma Inc., Abbisko Therapeutics Co, Ltd, Deciphera Pharmaceuticals, LLC, Daiichi Sankyo, AmMax Bio, Inc., AmMax Bio, Inc.,
[Nevada, United States] - DelveInsight's "Tendinopathy Market Insights, Epidemiology, and…
More Releases for Netherton
Netherton Syndrome Market In Depth Analysis 2022 To 2028-|Lifemax Laboratories, …
The report comes out as an intelligent and thorough assessment tool as well as a great resource that will help you to secure a position of strength in the global Netherton Syndrome market. It includes Porter's Five Forces and PESTLE analysis to equip your business with critical information and comparative data about the Global Netherton Syndrome Market. We have provided deep analysis of the vendor landscape to give you a…
Netherton Syndrome Market Qualitative Insights Key Enhancement & Share Analysis …
Netherton Syndrome Market suppliers assist organizations with forming existing cycles into better ones. These administrations additionally assist organizations with adjusting the requirements of developing outreach groups by instructing administrators to include appropriate preparing and deals execution rehearses. An employed advisor will regularly begin their educational plan by introducing a development model to project leads that features the likely ROI from the forthcoming counsel.
Get FREE Sample Copy of Netherton Syndrome Market…
Netherton Syndrome Market to Bolster the Revenue Growth US$ 74.31 million 2027- …
The Netherton Syndrome Market was valued at US$ 19.57 million in 2019 and is projected to reach US$ 74.31 million 2027; it is expected to grow at a CAGR of 20.3%from 2020 to 2027.
Netherton syndrome is a rare disorder characterized by trichorrhexis invaginata, atopic diathesis, and ichthyosiform erythroderma. The trichorrhexis invaginata indicates short and brittle hair, atopic diathesis represents susceptibility to allergy problems while ichthyosiform erythroderma encompasses red, inflamed, scaly…
Netherton Syndrome Market 2021 Global Industry Forecasts Analysis, Competitive L …
(United States, OR Poland): The Netherton Syndrome Market report is composed of major as well as secondary players describing their geographic footprint, products and services, business strategies, sales and market share, and recent developments among others. Furthermore, the Netherton Syndrome report highlights the numerous strategic initiatives such as product launches, new business agreements and collaborations, mergers and acquisitions, joint ventures, and technological advancements that have been implemented by the major market…
Netherton Syndrome Market 2021 Demands To Sustain in Future Industry Size, Growt …
(United States, OR Poland): The Global Netherton Syndrome Market Report makes available the current and forthcoming technical and financial details of the industry. The report contains an in-depth analysis of market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape. This report explores all the key factors affecting the growth of the global market, including demand-supply scenario, pricing structure, profit margins, production, and value chain analysis. The study involves the extensive…
Netherton Syndrome Market to Register Healthy Growth through 2027| Lifemax Labor …
Scaling skin, hair anomalies, increased susceptibility to atopic eczema, elevated IgE levels, and other symptoms characterise Netherton syndrome, a rare hereditary disorder. Netherton syndrome is passed down through the generations as an autosomal recessive condition. Netherton syndrome causes reddish skin (erythroderma) and a thick parchment-like layer of skin in newborns (collodion membrane). All of the skin is red and scaly.
The global Netherton Syndrome market size is projected to reach US$…
